Wang, Changrong http://orcid.org/0000-0001-9540-7089
Du, Jiangli http://orcid.org/0009-0006-9509-9112
Xiang, Xueping http://orcid.org/0000-0003-3545-4013
Wang, Yuyong http://orcid.org/0000-0002-7964-4436
Xiang, Jingjing http://orcid.org/0000-0002-2195-9726
Xu, Qiaoping http://orcid.org/0000-0002-8327-735X
Funding for this research was provided by:
Medical and Health Science and Technology Program of Zhejiang Province (2024KY177)
Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province (2020E10021)
Article History
Received: 29 July 2023
Accepted: 29 January 2024
First Online: 12 February 2024
Declarations
:
: The studies involving human participants were reviewed and approved by the Ethics Committee of the Affiliated Hangzhou First People’s Hospital, Westlake University School of Medicine, Institutional Review Board (Number of approval: IIT-2023–0142-01). This case was carried out in accordance with the Helsinki Declaration contents.
: Written informed consent was obtained from the patient's wife for the publication of any potentially identifiable images or data included in this article.
: The authors declare no competing interests.